S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
NASDAQ:HSTO

Histogen (HSTO) Stock Price, News & Analysis

$0.35
+0.03 (+9.38%)
(As of 03/4/2024 ET)
Today's Range
$0.32
$0.35
50-Day Range
$0.31
$0.40
52-Week Range
$0.28
$1.62
Volume
39,797 shs
Average Volume
7,105 shs
Market Capitalization
$1.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HSTO stock logo

About Histogen Stock (NASDAQ:HSTO)

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California.

HSTO Stock Price History

HSTO Stock News Headlines

Detecting Cancer in Mere Seconds: Early Investment Opportunity
A revolutionary cancer diagnostic tool is likely to come to fruition with anticipated FDA approval expected in just months. With the ability to detect cancer's "molecular fingerprint" in just seconds, it also offers far superior accuracy to current detection methods and reduces the need for invasive biopsies.
Histogen Inc HSTO
Detecting Cancer in Mere Seconds: Early Investment Opportunity
A revolutionary cancer diagnostic tool is likely to come to fruition with anticipated FDA approval expected in just months. With the ability to detect cancer's "molecular fingerprint" in just seconds, it also offers far superior accuracy to current detection methods and reduces the need for invasive biopsies.
Histogen Board Approves To Dissolve And Wind Down Operations
Histogen to Explore Strategic Alternatives
Short Volatility Alert: Histogen Inc
Why Is Histogen (HSTO) Stock Up 37% Today?
See More Headlines
Receive HSTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:HSTO
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-10,620,000.00
Net Margins
-65,142.11%
Pretax Margin
-65,178.96%

Debt

Sales & Book Value

Annual Sales
$3.77 million
Book Value
$3.13 per share

Miscellaneous

Free Float
4,131,000
Market Cap
$1.49 million
Optionable
Not Optionable
Beta
0.88
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ms. Susan A. Knudson (Age 60)
    President, CEO, CFO, COO, Chief Compliance Officer & Corporate Secretary
    Comp: $653.2k














HSTO Stock Analysis - Frequently Asked Questions

How have HSTO shares performed in 2024?

Histogen's stock was trading at $0.3077 on January 1st, 2024. Since then, HSTO stock has increased by 13.7% and is now trading at $0.35.
View the best growth stocks for 2024 here
.

How were Histogen's earnings last quarter?

Histogen Inc. (NASDAQ:HSTO) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($1.80) earnings per share for the quarter, beating the consensus estimate of ($2.20) by $0.40. The business had revenue of $0.59 million for the quarter. Histogen had a negative trailing twelve-month return on equity of 136.13% and a negative net margin of 65,142.11%. During the same period last year, the firm earned ($5.40) earnings per share.

When did Histogen's stock split?

Shares of Histogen reverse split on the morning of Friday, June 3rd 2022. The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Histogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Histogen investors own include Carnival Co. & (CCL), Intel (INTC), Genius Brands International (GNUS), Gilead Sciences (GILD), Clovis Oncology (CLVS), B2Gold (BTG), BIOLASE (BIOL), (BBI.V) (BBI), Advanced Micro Devices (AMD) and Akers Biosciences (AKER).

Who are Histogen's major shareholders?

Histogen's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Histogen?

Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HSTO) was last updated on 3/5/2024 by MarketBeat.com Staff